Creatine Kinase MB from Human Heart

<strong>Creatine Kinase MB from Human Heart</strong>_x000D_ <strong>Catalog number:</strong> B2012281_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 0.5 mg/mL_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20C_x000D_ <strong>Keywords:</strong> Creatine Kinase MB, CKMB isoenzyme, CK MB, CKB_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Fan J, Ma J, Xia N, Sun L, Li B, Liu H. Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction Clin Lab. 2017 Mar 1;63(3):427-433._x000D_ 2: Lindsey JB, Kennedy KF, Stolker JM, Gilchrist IC, Mukherjee D, Marso SP, Pencina MJ, Kleiman NS, Cohen DJ. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry Circ Cardiovasc Interv. 2011 Oct 1;4(5):474-80._x000D_ 3: Wu YW, Ho SK, Tseng WK, Yeh HI, Leu HB, Yin WH, Lin TH, Chang KC, Wang JH, Wu CC, Chen JW. Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease Sci Rep. 2020 Mar 27;10(1):5638._x000D_ 4: Nienhuis MB, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Suryapranata H, van't Hof AW; Zwolle Myocardial Infarction Study Group. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction Am Heart J. 2008 Apr;155(4):673-9._x000D_ 5: Mastro F, Guida P, Scrascia G, Rotunno C, Amorese L, Carrozzo A, Capone G, Paparella D. Cardiac troponin I and creatine kinase-MB release after different cardiac surgeries J Cardiovasc Med (Hagerstown). 2015 Jun;16(6):456-64._x000D_ 6: Jo MS, Lee J, Kim SY, Kwon HJ, Lee HK, Park DJ, Kim Y. Comparison between creatine kinase MB, heart-type fatty acid-binding protein, and cardiac troponin T for detecting myocardial ischemic injury after cardiac surgery Clin Chim Acta. 2019 Jan;488:174-178._x000D_ 7: Domanski MJ. Prognostic implications of troponin T and creatine kinase-MB elevation after coronary artery bypass grafting Am Heart J. 2012 Nov;164(5):636-7._x000D_ 8: Newby LK, Roe MT, Chen AY, Ohman EM, Christenson RH, Pollack CV Jr, Hoekstra JW, Peacock WF, Harrington RA, Jesse RL, Gibler WB, Peterson ED; CRUSADE Investigators. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes J Am Coll Cardiol. 2006 Jan 17;47(2):312-8._x000D_ 9: Cui X, Zhang T, Zheng J, Zhang J, Si P, Xu Y, Guo W, Liu Z, Li W, Ma J, Dong C, Shen Y, Cai C, He S. Children with coronavirus disease 2019: A review of demographic, clinical, laboratory, and imaging features in pediatric patients J Med Virol. 2020 Sep;92(9):1501-1510._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/24636545">10: Kruse JM, Enghard P, Schröder T, Hasper D, Kühnle Y, Jörres A, Storm C. Weak diagnostic performance of troponin, creatine kinase and creatine kinase-MB to diagnose or exclude myocardial infarction after successful resuscitation Int J Cardiol. 2014 May 1;173(2):216-21. </a>_x000D_ _x000D_ <strong>Products Related to Creatine Kinase MB from Human Heart can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>